
    
      PROTOCOL OUTLINE:

      This is a dose escalation study.

      Patients receive amifostine IV over 3-5 minutes three times a week for three weeks.

      Cohorts of 3 patients receive one of three dose levels of amifostine. The maximum tolerated
      dose is defined as the dose preceding that at which 2 of 6 patients experience dose limiting
      toxicity.

      Patients are followed weekly for 3 weeks.
    
  